Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)

Eligibility Criteria

• * Significant comorbidity that, in the investigator's opinion, would results in the patient being unable to safely undergo the procedure or participate in the clinical investigation.
• * Patients with an estimated Glomerular Filtration Rate (eGFR) \< 25 ml/min/1.73m2
• * Patients with an in vivo IVC filter, abnormal IVC or femoral venous anatomy or known congenital malformation or absence of IVC or occlusive or free-floating thrombus in the IVC.
• * Patients who have severe right sided valvular disease or a right sided mechanical valve.
• * Patients with a cardiac resynchronization therapy device implanted ≤ 3 months to prior to screening.
• * Patients who have undergone invasive cardiac surgery in the 3 months prior to screening.
• * Patients who have undergone percutaneous valve / structural heart intervention in in the 3 months prior to screening.
• * Patients who have received heart transplant or a ventricular assist device or planned for advanced therapies within the next year.
• * Patients with conditions associated with occlusion of the IVC, iliac or common femoral veins.